Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)

PHASE3CompletedINTERVENTIONAL
Enrollment

551

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2014

Conditions
LeukemiaMyeloproliferative DisordersMyelodysplastic-Myeloproliferative Diseases
Interventions
BIOLOGICAL

Allogeneic bone marrow transplantation

Bone marrow transplant from HLA compatible unrelated donors.

BIOLOGICAL

Peripheral blood stem cell transplantation

Peripheral blood transplant from HLA compatible unrelated donors.

Trial Locations (45)

11040

Cohen Children's Hospital, New Hyde Park

15232

University of Pittsburgh Cancer Institute, Pittsburgh

19104

University of Pennsylvania Cancer Center, Philadelphia

21228

University of Maryland, Baltimore

27705

Duke University Medical Center, Durham

30322

Emory University, Atlanta

35294

University of Alabama at Birmingham, Birmingham

43210

Ohio State/Arthur G. James Cancer Hospital, Columbus

46237

IBMT (Indiana Blood and Marrow Transplant) at St Francis Franciscan Health, Indianapolis

52242

University of Iowa Hospitals and Clinics, Iowa City

55455

University of Minnesota, Minneapolis

55905

Mayo Clinic Cancer Center, Rochester

60153

Loyola University, Maywood

63110

Washington University/Barnes Jewish Hospital, St Louis

Washington University/St. Louis Children's Hospital, St Louis

66160

University of Kansas Hospital, Kansas City

73104

University of Oklahoma Medical Center, Oklahoma City

77030

Baylor University Medical Center, Dallas

78229

Texas Transplant Institute, San Antonio

84112

Utah BMT/Primary Children's Medical Center, Salt Lake City

84132

Utah BMT/University of Utah Medical School, Salt Lake City

91010

City of Hope National Medical Center, Duarte

94143

University of California, San Francisco, San Francisco

94305

Stanford Hospital and Clinics, Stanford

97239

Oregon Health Sciences University, Portland

98104

Fred Hutchinson Cancer Research Center, Seattle

92093-0960

UCSD Cancer Center, La Jolla

32610-100277

University of Florida College of Medicine (Shands), Gainesville

02114

DFCI/Brigham & Women's, Boston

48109-0942

University of Michigan Medical Center, Ann Arbor

68198-3330

University of Nebraska Medical Center, Omaha

07601

Hackensack University Medical Center Cancer Center, Hackensack

14263-0001

Roswell Park Cancer Institute, Buffalo

27157-1082

Wake Forest University Health Sciences, Winston-Salem

97239-3098

Oregon Health & Science University (Peds), Portland

37232-6838

Vanderbilt University, Nashville

77030-2399

Baylor College of Medicine/The Methodist Hospital, Houston

77030-4009

University of Texas/MD Anderson CRC, Houston

23298-0037

Virginia Commonwealth University MCV Hospitals, Richmond

T2N 4N2

Tom Baker Cancer Centre, Calgary, Calgary

V5Z1M9

Vancouver General Hospital, Vancouver

Unknown

Hamilton Health Sciences - McMaster Site, Hamilton

Ottawa Hospital, Ottawa

Queen Elizabeth II Health Sciences Centre - Halifax, Halifax

M5G 2M9

University of Toronto, Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Blood and Marrow Transplant Clinical Trials Network

NETWORK

collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Marrow Donor Program

OTHER

lead

Medical College of Wisconsin

OTHER

NCT00075816 - Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) | Biotech Hunter | Biotech Hunter